Showing results (11-20 of 64) with videos related to
Sort By:
Pageof 7
Neuroscience Research|March 31, 2021
Sleep disturbance induces depressive behaviors and neuroinflammation by altering the circadian oscillations of clock genes in ratsChen Xing, Yanzhao Zhou, Huan Xu, et al.Cell Biology International|December 10, 2015
Dissolved oxygen concentration in the medium during cell culture: Defects and improvementsKuan Zhang, Tong Zhao, Xin Huang, et al.Scientific Reports|October 4, 2017
A Therapeutic Peptide Vaccine Against PCSK9Yajie Pan, Yanzhao Zhou, Hailang Wu, et al.Journal of Hepatocellular Carcinoma|June 30, 2021
Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation CriteriaYanzhao Zhou, Yi Yang, Bingyan Zhou, et al.Journal of Hepatocellular Carcinoma|July 1, 2024
The Influence of Visceral Adiposity on Overall Survival: Exploring "Obesity Paradox" Among Hepatocellular Carcinoma Patients Who Receiving ImmunotherapyYanzhao Zhou, Jingzhong Ouyang, Hongcai Yang, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 22, 2025
Development of a circulating tumor DNA methylation biomarker panel for hepatocellular carcinoma detectionYanzhao Zhou, Beilin Zhang, Ke Yang, et al.Pflugers Archiv : European Journal of Physiology|November 23, 2023
Intermittent hypoxia training effectively protects against cognitive decline caused by acute hypoxia exposureGuangbo Zhang, Guochun Yang, Yanzhao Zhou, et al.La Radiologia Medica|December 13, 2024
How different body compositions affect the prognosis of HCC undergoing immunotherapy: the paradoxical phenomenon of BMIJingzhong Ouyang, Yi Yang, Ying Xu, et al.High Altitude Medicine & Biology|April 29, 2022
Preliminary Intermittent Hypoxia Training Alleviates the Damage of Sustained Normobaric Hypoxia on Human Hematological Indexes and Cerebral White MatterGuangbo Zhang, Yanzhao Zhou, Zhengtao Cao, et al.Journal of Hepatocellular Carcinoma|September 13, 2023
Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark AnalysisJingzhong Ouyang, Zhengzheng Wang, Kun Yuan, et al.Pageof 7